Dianthus Therapeutics, Inc. /DE/
Developing selective antibody therapies for severe autoimmune diseases.
DNTH | US
Overview
Corporate Details
- ISIN(s):
- US2528281080 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 7 TIMES SQUARE, 10036 NEW YORK
- Website:
- https://dianthustx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing next-generation therapies for severe autoimmune diseases. The company focuses on designing and engineering potentially best-in-class monoclonal antibodies with improved potency, high selectivity, and extended half-lives. Its lead candidate, claseprubart (DNTH103), is an antibody that selectively targets the active C1s complement protein. The pipeline also includes DNTH212, a bifunctional inhibitor targeting Type 1 IFN suppression and B cell modulation. Dianthus's therapeutic approach aims to enable less frequent and more convenient self-administered subcutaneous injections, with the goal of improving clinical outcomes and quality of life for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Dianthus Therapeutics, Inc. /DE/ filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Dianthus Therapeutics, Inc. /DE/
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Dianthus Therapeutics, Inc. /DE/ via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
